Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Aberrant basal ganglia metabolism in fragile X syndrome: a magnetic resonance spectroscopy study.

Bruno JL, Shelly EW, Quintin EM, Rostami M, Patnaik S, Spielman D, Mayer D, Gu M, Lightbody AA, Reiss AL.

J Neurodev Disord. 2013 Aug 28;5(1):20. doi: 10.1186/1866-1955-5-20.

2.

Cognitive and behavioral correlates of caudate subregion shape variation in fragile X syndrome.

Peng DX, Kelley RG, Quintin EM, Raman M, Thompson PM, Reiss AL.

Hum Brain Mapp. 2014 Jun;35(6):2861-8. doi: 10.1002/hbm.22376. Epub 2013 Sep 13.

PMID:
24038999
3.

Altered Brain Network Segregation in Fragile X Syndrome Revealed by Structural Connectomics.

Bruno JL, Hosseini SMH, Saggar M, Quintin EM, Raman MM, Reiss AL.

Cereb Cortex. 2017 Mar 1;27(3):2249-2259. doi: 10.1093/cercor/bhw055.

PMID:
27009247
4.

Region-specific alterations in brain development in one- to three-year-old boys with fragile X syndrome.

Hoeft F, Carter JC, Lightbody AA, Cody Hazlett H, Piven J, Reiss AL.

Proc Natl Acad Sci U S A. 2010 May 18;107(20):9335-9. doi: 10.1073/pnas.1002762107. Epub 2010 May 3.

5.

Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.

Sheridan SD, Theriault KM, Reis SA, Zhou F, Madison JM, Daheron L, Loring JF, Haggarty SJ.

PLoS One. 2011;6(10):e26203. doi: 10.1371/journal.pone.0026203. Epub 2011 Oct 12.

6.

BDNF in fragile X syndrome.

Castrén ML, Castrén E.

Neuropharmacology. 2014 Jan;76 Pt C:729-36. doi: 10.1016/j.neuropharm.2013.05.018. Epub 2013 May 29. Review.

PMID:
23727436
7.

Neurochemical evaluation of brain function with 1H magnetic resonance spectroscopy in patients with fragile X syndrome.

Utine GE, Akpınar B, Arslan U, Kiper PÖ, Volkan-Salancı B, Alanay Y, Aktaş D, Haliloğlu G, Oğuz KK, Boduroğlu K, Alikaşifoğlu M.

Am J Med Genet A. 2014 Jan;164A(1):99-105. doi: 10.1002/ajmg.a.36207. Epub 2013 Nov 20.

PMID:
24259304
8.

Alterations of visual and auditory evoked potentials in fragile X syndrome.

Knoth IS, Vannasing P, Major P, Michaud JL, Lippé S.

Int J Dev Neurosci. 2014 Aug;36:90-7. doi: 10.1016/j.ijdevneu.2014.05.003. Epub 2014 May 27.

PMID:
24875778
9.

Aberrant frontal lobe maturation in adolescents with fragile X syndrome is related to delayed cognitive maturation.

Bray S, Hirt M, Jo B, Hall SS, Lightbody AA, Walter E, Chen K, Patnaik S, Reiss AL.

Biol Psychiatry. 2011 Nov 1;70(9):852-8. doi: 10.1016/j.biopsych.2011.05.038. Epub 2011 Jul 29.

10.

Progress toward therapeutic potential for AFQ056 in Fragile X syndrome.

Sourial M, Cheng C, Doering LC.

J Exp Pharmacol. 2013 Jul 16;5:45-54. doi: 10.2147/JEP.S27044. eCollection 2013. Review.

11.

Neuroanatomy of fragile X syndrome is associated with aberrant behavior and the fragile X mental retardation protein (FMRP).

Gothelf D, Furfaro JA, Hoeft F, Eckert MA, Hall SS, O'Hara R, Erba HW, Ringel J, Hayashi KM, Patnaik S, Golianu B, Kraemer HC, Thompson PM, Piven J, Reiss AL.

Ann Neurol. 2008 Jan;63(1):40-51.

12.

Differential impact of the FMR1 gene on visual processing in fragile X syndrome.

Kogan CS, Boutet I, Cornish K, Zangenehpour S, Mullen KT, Holden JJ, Der Kaloustian VM, Andermann E, Chaudhuri A.

Brain. 2004 Mar;127(Pt 3):591-601. Epub 2004 Jan 21.

PMID:
14736752
13.

Identifying large-scale brain networks in fragile X syndrome.

Hall SS, Jiang H, Reiss AL, Greicius MD.

JAMA Psychiatry. 2013 Nov;70(11):1215-23. doi: 10.1001/jamapsychiatry.2013.247.

14.

Modulation of the GABAergic pathway for the treatment of fragile X syndrome.

Lozano R, Hare EB, Hagerman RJ.

Neuropsychiatr Dis Treat. 2014 Sep 16;10:1769-79. doi: 10.2147/NDT.S42919. eCollection 2014. Review.

15.

The neuroanatomy and neuroendocrinology of fragile X syndrome.

Hessl D, Rivera SM, Reiss AL.

Ment Retard Dev Disabil Res Rev. 2004;10(1):17-24. Review.

PMID:
14994284
16.

Molecular and cellular aspects of mental retardation in the Fragile X syndrome: from gene mutation/s to spine dysmorphogenesis.

De Rubeis S, Fernández E, Buzzi A, Di Marino D, Bagni C.

Adv Exp Med Biol. 2012;970:517-51. doi: 10.1007/978-3-7091-0932-8_23. Review.

PMID:
22351071
17.

microRNAs and Fragile X Syndrome.

Lin SL.

Adv Exp Med Biol. 2015;888:107-21. doi: 10.1007/978-3-319-22671-2_7.

PMID:
26663181
18.

Mechanism-based treatments in neurodevelopmental disorders: fragile X syndrome.

Berry-Kravis E.

Pediatr Neurol. 2014 Apr;50(4):297-302. doi: 10.1016/j.pediatrneurol.2013.12.001. Epub 2013 Dec 4. Review.

PMID:
24518745
19.

Whole-brain expression analysis of FMRP in adult monkey and its relationship to cognitive deficits in fragile X syndrome.

Zangenehpour S, Cornish KM, Chaudhuri A.

Brain Res. 2009 Apr 6;1264:76-84. doi: 10.1016/j.brainres.2009.01.059. Epub 2009 Feb 6.

PMID:
19368811
20.

Morphometric spatial patterns differentiating boys with fragile X syndrome, typically developing boys, and developmentally delayed boys aged 1 to 3 years.

Hoeft F, Lightbody AA, Hazlett HC, Patnaik S, Piven J, Reiss AL.

Arch Gen Psychiatry. 2008 Sep;65(9):1087-97. doi: 10.1001/archpsyc.65.9.1087.

Supplemental Content

Support Center